SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Aventus

Aventus ($AVT.X) is trending as community members highlight its low market cap and potential for a breakout, with some comparing it to other trending tokens. Recent company updates on LinkedIn, particularly partnerships and the appchain model, are generating discussion, as are technical analyses suggesting bullish patterns. Some traders are expressing frustration with $AVT.X's inability to hold gains.

"Shina Inu is a decentralized meme token on the Ethereum blockchain. Its mission is to give back to the crypto community, give to charity, and win the heart of the greatest token of all time, Shiba Inu!   Shina Token is a very fun meme token project that has sold many rare and beautiful NFTs. NFT sales are used to support the team and provide upcoming features such as exclusive access to events and rewards that will soon be announced."

Shina Inu

Shina Inu is trending as community members highlight its strong chart setup, accumulation patterns, and potential for a breakout. The focus is on bullish technical indicators and growing momentum, with some suggesting it could be the next big community-driven crypto run. Overall, the community sentiment points towards anticipation for a significant upward move.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Conversations around DJT are currently focused on political division and the recent death of Charlie Kirk, with community members expressing strong opinions and engaging in heated debates. Some users are pointing fingers and assigning blame, while others are calling for unity and an end to political violence. The stock appears to be heavily influenced by broader socio-political narratives.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is surging, sparking excitement among its community who are eyeing potential gains and referencing a possible DOJE ETF. Discussions revolve around holding strategies, potential price targets, and whether this rally has enough momentum to reach previous highs. Some community members are suggesting that it is on track to reach $1 soon.

Ainalyzr is a versatile and engaging platform designed to provide crypto traders with advanced tools and a fun, interactive environment. Powered by the Ainalyzr token, it offers real-time analysis of Solana-based tokens, gamified trading tools, and a space for users to explore market trends and make data-driven decisions. Ainalyzr merges functionality and entertainment, appealing to both seasoned and novice traders.

AInalyzr

AInalyzr ($AINAL.X) is gaining attention as community members anticipate a potential breakout, citing bullish chart patterns and encouraging others to "stack" before it's too late. The crypto is being touted as a hidden gem with "rocket" potential, with many emphasizing the opportunity to get in early. Conversations suggest a strong sense of conviction among those already invested.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The crypto "crow with knife" ($CAW.X) is trending, driven by community enthusiasm and its growing presence as a meme coin, particularly within the Cronos ($CRO.X) ecosystem.  Active discussions revolve around its unique branding and potential, with supporters emphasizing its community-driven nature and multichain functionality across $SOL.X, $CRO.X, and $ETH.X.

"What's Updog?" is a Community Led token.

UpDog

UpDog is trending as community members highlight its charitable donations to dog shelters, with many expressing excitement about the project's potential and comparing it to other meme coins. The community is actively discussing the coin's mission and anticipating further gains, viewing it as a 'dog-coin' with a cause. There is also increased interest around 'what is UpDog?'

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending as the community rallies around a potential breakout, fueled by bullish chart patterns and significant accumulation by key players. Many are pointing to $AINAL.X as the next big opportunity within the Solana ecosystem, urging others to get in early before a potential surge. The overall sentiment suggests strong momentum and anticipation for further gains in the near future.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cash is trending as traders assess its potential amid the broader crypto market's movements, with some highlighting its utility and faster transactions. Community members are discussing key resistance levels and speculating on future price targets, while others debate its long-term viability compared to Bitcoin. A potential spot ETF is also being discussed.

Trump For President

$TRUMP.X is trending amidst heated debates regarding its purpose and future, with some community members labeling it a scam while others anticipate a surge. Speculation is fueled by the connection to Donald Trump and the broader meme coin market, creating volatile price action. Some users express concerns about the coin's utility, while others discuss potential price movements and speculate on Trump's involvement.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MLTX Stock Gains 18% as Merck Reportedly Eyes Buyout

Wall Street Analysts Think MOONLAKE IMMUNO (MLTX) Could Surge 106.62%: Read This Before Placing a Bet

MoonLake Immunotherapeutics, a clinical-stage biotech firm valued at $2.6 billion, is generating excitement with its experimental treatment for hidradenitis suppurativa (HS), a chronic and painful skin condition.&nbsp;On Friday, Goldman Sachs upgraded the stock to a&nbsp;'Buy' from&nbsp;'Neutral,' with analyst Richard Law raising the price target from $62 to $82 — an 85% upside from current levels, CNBC&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.cnbc.com/2025/01/17/this-little-known-biotech-stock-is-a-buy-thats-primed-to-double-in-price-goldman-says.html">reported</a>.While MoonLake is gaining traction among institutional investors, it remains underfollowed on Stocktwits, with fewer than 600 watchers.&nbsp;Over the past year, retail interest has been budding, with a 12% increase in followers, even as the stock has fallen 26%.Law reportedly believes MoonLake's experimental nanobody treatment, sonelokimab (SLK), holds transformative potential.&nbsp;SLK demonstrated impressive efficacy in phase 2 trials, leading to optimism about its success in phase 3.&nbsp;Additionally, SLK's inclusion of AbbVie's Skyrizi — currently the standard of care for psoriatic arthritis (PsA) — as a reference treatment offers a key differentiator, according to the analyst.Law suggests that while this adds some risk, the potential to position SLK as superior in a competitive market far outweighs the drawbacks.Goldman Sachs isn't alone in its optimism. Oppenheimer included MoonLake among its top biotech picks for 2025, alongside Capricor, Gilead, Kymera, Praxis, and Prothena.&nbsp;The brokerage sees biotech equities as undervalued relative to other sectors, with strong catalysts like lower interest rates, robust M&amp;A prospects, and transformative data releases creating a favorable backdrop this year.MoonLake ended the third quarter (Q3) of 2024 with $493.9 million in cash, cash equivalents, and marketable securities, which the company said provides a runway through 2026.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

Over the past year, retail interest has been budding, with a 12% increase in followers, even as the stock has fallen 26%.

Goldman Sachs Thinks Mid-Cap Biotech MoonLake Could Soar Over 80%: Is Retail Watching Closely?

Oppenheimer has included MoonLake among its top biotech picks for 2025, alongside Capricor, Gilead, Kymera, Praxis, and Prothena.

Equity

Buy Rating for MoonLake Immunotherapeutics Backed by Strong Prospects for Lead Candidate and Financial Stability

Ram Selvaraju, an analyst from H.C. Wainwright, reiterated the Buy rating on MoonLake Immunotherapeutics (MLTX Research Report). The associated p...

TimesSquare Capital Management LLC Has $23.44 Million Position in MoonLake Immunotherapeutics (NASDAQ:MLTX)

TimesSquare Capital Management LLC raised its holdings in MoonLake Immunotherapeutics (NASDAQ:MLTX  Free Report) by 1,270.7% in the 3rd quarter, according to the company in its most recent...

MoonLake announces significant improvements with Nanobody  sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other important updates at its R&D Day

MoonLake announces significant improvements with Nanobody sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other important updates at its R&D Day Positive 24-week data from the...

MoonLake Immunotherapeutics (NASDAQ:MLTX) Forecasted to Earn Q1 2024 Earnings of ($0.30) Per Share

MoonLake Immunotherapeutics (NASDAQ:MLTX  Free Report)  Analysts at HC Wainwright raised their Q1 2024 earnings estimates for MoonLake Immunotherapeutics in a note issued to investors...

HC Wainwright Weighs in on MoonLake Immunotherapeutics' Q1 2025 Earnings (NASDAQ:MLTX)

MoonLake Immunotherapeutics (NASDAQ:MLTX  Free Report)  HC Wainwright issued their Q1 2025 earnings estimates for shares of MoonLake Immunotherapeutics in a research note issued on...

FY2028 Earnings Estimate for MoonLake Immunotherapeutics (NASDAQ:MLTX) Issued By Leerink Partnrs

MoonLake Immunotherapeutics (NASDAQ:MLTX  Free Report)  Stock analysts at Leerink Partnrs lifted their FY2028 earnings per share (EPS) estimates for shares of MoonLake...

Wedbush Reaffirms Outperform Rating for MoonLake Immunotherapeutics (NASDAQ:MLTX)

Wedbush reissued their outperform rating on shares of MoonLake Immunotherapeutics (NASDAQ:MLTX  Free Report) in a research note issued to investors on Friday, Benzinga reports. The firm...

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$0.87	--	--	N/A
Q2 '25	-$0.71	-$0.87	-21.82%	MISSED
Q1 '25	-$0.75	-$0.63	16.44%	BEAT
Q4 '24	-$0.62	-$0.72	-16.08%	MISSED
Q3 '24	-$0.44	-$0.56	-28.60%	MISSED

MLTX
MoonLake Immunotherapeutics - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest MLTX News

MLTX MoonLake Immunotherapeutics - Ordinary Shares - Class A